Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer

Phase 1 Completed 15 enrolled Stanford University National Cancer Institute (NCI) · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the maximum-tolerated dose (MTD) of sodium selenite when administered in combination with radiation therapy to subjects with metastatic cancer based on safety and tolerability.

Timeline

Start: 2014-07
Primary completion: 2018-05
Completion: 2018-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	sodium selenite	Unknown	—	Oral

Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer

Summary

Timeline

Drugs

Indications